Chad’s practice focuses on the defense of pharmaceutical manufacturers in complex litigation in federal and state courts throughout the United States.

The products Chad has defended include antidepressants, attention-deficit/hyperactivity disorder medication, diethylstilbestrol, automatic implantable cardioverter-defibrillators, hormone replacement therapy and over-the-counter medications.

Chad's prior experience in the firm includes e-discovery issues concerning data privacy and protection. He also has experience working on privacy issues involving data protection regulations in the European Union, Latin America, North America and Australia.


Publications

A Missed Opportunity to Definitively Apply the Central Hudson Test, 26 Creighton Law Review 1155 (1993).